Get the Stockscreener App
0.7597
0.29%
-0.0022
After Hours:
.78
0.0203
+2.67%
China Pharma Holdings Inc. stock is traded at $0.7597, with a volume of 32,609.
It is down -0.29% in the last 24 hours and up +17.20% over the past month.
China Pharma Holdings, Inc. develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People's Republic of China. The company offers products in the form of dry powder injectables, liquid injectables, tablets, capsules, cephalosporin oral solutions, and granules. The company's products include Cerebroprotein Hydroloysate injection to treat memory decline and attention deficit; Gastrodin injection for tiredness, loss of concentration, poor sleep, and traumatic syndromes of the brain; Propylgallate and Ozagrel Sodium to treat cerebral thrombosis, coronary heart disease, and after surgery complications; Alginic Sodium Diester injection for ischemic heart, cerebrovascular, and high lipoprotein blood diseases; Bumetanide to treat edema diseases; and Candesartan for hypertension. It also provides Roxithromycin dispersible tablets for pharyngitis and tonsillitis; Cefaclor dispersible tablets for tympanitis, lower respiratory tract infection, urinary tract infections, and skin/skin tissue infection; Cefalexin capsules for acute tonsillitis; Anhydroandrographolide for ischemic heart, cerebrovascular, and high lipoprotein blood diseases; Clarithromycin granules and capsules; and Naproxen Sodium and PseudophedrineHydrochlorida sustained release tablets. In addition, the company offers Hepatocyte growth-promoting factor, Tiopronin, Compound Ammonium Glycyrrhetate S, and Omeparzole for the treatment of digestive diseases. Further, it provides Vitamin B6 injection; and Granisetron Hydrochloride injection to treat nausea and vomiting caused by radiotherapy and chemotherapy during the treatment of malignant tumors. The company offers its products through distributors, as well as through its network of 16 sales offices and approximately 1,000 sales representatives. China Pharma Holdings, Inc. is headquartered in Haikou, the People's Republic of China.
See More
Previous Close:
$0.7619
Open:
$0.675601
24h Volume:
32,609
Relative Volume:
0.13
Market Cap:
$30.78M
Revenue:
$4.14M
Net Income/Loss:
$-3.19M
P/E Ratio:
-1.0169
EPS:
-0.7471
Net Cash Flow:
$11,000
1W Performance:
-26.95%
1M Performance:
+17.20%
6M Performance:
-52.52%
1Y Performance:
-65.62%
1-Day Range:
$0.6706
$0.78
1-Week Range:
$0.60
$1.02
52-Week Range:
$0.3818
$2.3392
China Pharma Holdings Inc. Stock (CPHI) Company Profile
Name
China Pharma Holdings Inc.
Sector
Phone
86 898 6681 1730
Address
No. 17, Jinpan Road, Second Floor, Haikou
Compare CPHI vs TAK, HLN, TEVA, ZTS, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CPHI
China Pharma Holdings Inc.
|
0.7597 | 30.87M | 4.14M | -3.19M | 11,000 | -0.7471 |
TAK
Takeda Pharmaceutical Co Adr
|
16.25 | 52.07B | 29.91B | 1.30B | 3.49B | 0.4056 |
HLN
Haleon Plc Adr
|
9.29 | 41.28B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
34.07 | 39.78B | 17.53B | 1.58B | 444.18M | 1.3457 |
ZTS
Zoetis Inc
|
81.32 | 33.57B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
568.43 | 24.02B | 3.17B | 1.29B | 1.01B | 27.09 |
China Pharma Holdings Inc. Stock (CPHI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-08-10 | Initiated | Rodman & Renshaw | Mkt Outperform |
China Pharma Holdings Inc. Stock (CPHI) Latest News
CPHI Stock Chart | CHINA PHARMA HOLDINGS INC (NYSEARCA:CPHI) - ChartMill
12 Health Care Stocks Moving In Monday's Intraday Session - Sahm
China Pharma Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
China Pharma Holdings, Inc. States It Knows of No Events That Could Have Caused Unusual Market Activity - digitalmore.co
China Pharma says unaware of reason for unusual trading - Investing.com
China Pharma says unaware of reason for unusual trading By Investing.com - Investing.com Nigeria
China Pharma Holdings IncNYSE American contacts China Pharma regarding unusual market activity on May 12 and 13 - marketscreener.com
Unusual volume stocks are being observed in Wednesday's session. - ChartMill
TradingKey - tradingkey.com
12 Health Care Stocks Moving In Tuesday's After-Market Session - Sahm
These stocks are moving in today's after hours session - ChartMill
C3 AI Announces Q4 and Fiscal Year 2026 Preliminary Results: Tom Siebel Returns as CEO, Reports Revenue Within Guidance and Improved Operating Losses - Minichart
Pharma ETFs: Your Key to Diversification in the Pharmaceutical Sector - Investing News Network
CPHI Stock Price, Quote & Chart | CHINA PHARMA HOLDINGS INC (NYSEARCA:CPHI) - ChartMill
US Stock Market Trends: Updated Data Analysis & Real-Time Quotes - TradingKey
China NT Pharma Group Company Limited Announces Board and Committee Changes, Effective May 8, 2026 - marketscreener.com
CPHI PE Ratio & Valuation, Is CPHI Overvalued - Intellectia AI
China NT Pharma Group Quarterly Update on Action Plans for Disclaimer of Opinion Resolution and AI Health Business Transformation 1 - Minichart
Chinese firm Livzon secures control of Vietnam’s pharma giant Imexpharm in $228 mln deal - Theinvestor
Why Seagate Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket - Benzinga
Top LosersStock ScreenerSnapshot - Finviz
CPHI Technical Analysis & ETF Price Forecast - Intellectia AI
EBITDA per share of China Pharma Holdings, Inc. – AMEX:CPHI - TradingView
EBIT per share of China Pharma Holdings, Inc. – MUN:XQJ0 - TradingView
Regeneron CEO Defends Pharma, Warns China Will ‘Pass Us Right By’ After Announcing Free Gene Therapy For Hearing Loss - Stocktwits
Vertex Pharmaceuticals Incorporated $VRTX Shares Purchased by China Universal Asset Management Co. Ltd. - MarketBeat
Shuttle Pharma (SHPH) proxy asks investors to OK major reverse split range - Stock Titan
China Pharma (CPHI) Stock Dividend Analysis (+1.54%) 2026-04-16Price Action - Cổng thông tin điện tử tỉnh Lào Cai
China Pharma Holdings, Inc. (CPHI) - Minichart
Trading Recap: Does ALLT have strong EBITDA margins2026 Growth vs Value & AI Driven Stock Reports - baoquankhu1.vn
Aug Sentiment: Why is Alexanders Inc stock going downProduct Launch & Weekly High Momentum Picks - baoquankhu1.vn
Is China Pharma (CPHI) Stock a Growth Play | Price at $0.65, Up 0.62%Intraday Trading - Newser
symbol__ Stock Quote Price and Forecast - CNN
US Market Recap: Can PBHC generate free cash flowLayoff News & Smart Money Movement Alerts - baoquankhu1.vn
Is China Pharma (CPHI) Stock defensive in downturns | Price at $0.60, Down 2.42%Leading Diagonal - Newser
Ascentage Pharma Group International (NASDAQ:AAPG) Raised to "Strong-Buy" at China Intl Cap - MarketBeat
Is Quantum-Si Incorporated (QSI) Stock tied to economic cycles | QSI Q4 Earnings: Beats Estimates by $0.04Sell Rating - Xã Châu Thành
Market Catalysts: Is China Pharma Holdings Incs ROE strong enough2026 Volume Leaders & High Conviction Trade Alerts - baoquankhu1.vn
Earnings Risk: Can China Pharma Holdings Inc expand its profit marginsVolume Spike & Low Drawdown Trading Strategies - baoquankhu1.vn
Is Immunome (IMNM) Stock Expanding | Price at $22.19, Up 1.60%Bullish Pattern - Xã Thanh Hà
China Pharma (NYSE:CPHI) & Acerus Pharmaceuticals (OTCMKTS:ASPCF) Financial Comparison - Defense World
CUPR PE Ratio & Valuation, Is CUPR Overvalued - Intellectia AI
DRMA Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Stock List: Research Stocks from Around the World - GuruFocus
China Pharma Holdings, Inc. (XQJ.DE) Analyst insights, Price targets and Recommendations - Yahoo Finance Singapore
China Pharma Holdings, Inc. (XQJ.DE) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
CPHI Q3 2011 Earnings: China Pharma Holdings Inc. misses EPS estimates - Newser
China Pharma Delays 10-K but Shows Narrowing Losses - The Globe and Mail
China Pharma Holdings 2026 Annual Report: Strategic Focus on Generic Drugs, Market Expansion, and Innovation in China’s Pharmaceutical Industry - Minichart
China Pharma Holdings Files For Non-Timely 10-K With US SEC - TradingView
China Pharma Holdings 10-K: Revenue $4.14M, Loss per Share $(0.74) - TradingView — Track All Markets
China Pharma Holdings Inc. Stock (CPHI) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.92%
4.44%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):